Lymph nodes and extranodal lymphoid tissue, spleen and thymus


Common Clinical Problems Arising From Diseases of Lymph Nodes, Extranodal Lymphoid Tissues, Spleen and Thymus

Pathological basis of signs and symptoms attributable to lymphoid, splenic or thymic disorders

Sign or symptom Pathological basis
Enlarged lymph nodes Hyperplasia of lymphoid components responding to infection or other antigenic stimulation (e.g. Epstein–Barr virus [EBV] in infectious mononucleosis)
Granuloma formation in response to persistent antigens (e.g. tuberculosis, toxoplasmosis, sarcoidosis). Neoplastic infiltration:

  • primary — lymphoma

  • secondary — metastasis from solid cancers

Enlarged spleen Congestion (e.g. heart failure, portal hypertension)
Autoimmune red cell and/or platelet destruction in splenic red pulp
Storage disorders involving red pulp macrophages
Neoplasm (e.g. leukaemia, lymphoma)
Susceptibility to infection Immune deficiency:

  • inherited

  • acquired (e.g. HIV/AIDS, iatrogenic immunosuppression, hyposplenism)

Weight loss/fever Inflammatory cytokines produced in reactive or neoplastic lymphoid tissue affecting thermoregulatory centre in hypothalamus
Muscle weakness (myasthenia gravis) Autoimmune reaction targeting neuromuscular junctions; may accompany thymic hyperplasia or neoplasia
Howell–Jolly inclusions in red cells Persistence of DNA fragments in red cells due to hyposplenism

Lymph Nodes

Normal Structure and Function

Lymph nodes are encapsulated collections of lymphoid tissue that are usually ovoid and, unless stimulated or abnormally enlarged, up to about 1 cm in diameter. They are distributed along lymphatic vessels throughout the body and are more numerous where these vessels converge (e.g. roots of limbs, neck, mediastinum and pelvis).

Microarchitecture and functional anatomy

Lymph nodes are enclosed by a delicate connective tissue capsule, from which septa extend into the substance of the node and provide a framework for cellular elements within. Beneath the capsule is the subcapsular sinus, into which afferent lymphatics drain after penetrating the capsule. Lymph from the subcapsular sinus percolates through the node, allowing cell traffic and interactions necessary for immune reactions. Antigenic material in lymphatic fluid also interacts with fixed lymphoid tissue components as the lymph passes through. Lymph then enters medullary cords and sinuses that drain into the lymph node hilum. These sinuses merge at the hilum to form an efferent lymphatic through which lymph rejoins the extranodal lymphatic circulation.

Three distinct microanatomical regions can be recognised within normal lymph nodes (see also Ch. 8 ).

  • Cortex , composed of nodules of B lymphocytes forming unstimulated (primary) follicles or reactive follicles with germinal centres and mantle zones. Follicles are normally arrayed beneath the capsule and do not extend into the medulla.

  • Paracortex , which is the main area for T-lymphocyte trafficking and interactions within the node. It forms the interfollicular tissue surrounding cortical follicles and extends further into the parenchyma to merge with the medulla.

  • Medulla , containing cords and sinuses which drain into the hilum. Medullary cords are rich in plasma cells.

These regions also contain fixed and mobile stromal cells which have specialised functions, particularly antigen presentation, contributing to the immune system.

Cortex

Germinal centres of lymph node follicles are the principal sites of B-cell activation in response to antigenic challenge. Antigen–antibody complexes entering the lymph node through afferent lymphatics are captured, via their fraction complement-binding (Fc) receptors, onto surface projections of specialised antigen-presenting cells called follicular dendritic cells (FDC). These are mesenchymal cells that are normally restricted to primary follicles and germinal centres. They have long cytoplasmic processes linked by desmosomes to form a network throughout the germinal centre. Antigen on FDC surfaces is presented to ‘naïve’ B lymphocytes in the presence of T-helper cells; these B cells subsequently undergo morphological and functional changes to become antibody-producing effector cells or memory cells. After antigenic challenge, the initial step in B-cell transformation in the germinal centre is production of a centroblast , a rapidly dividing cell responsible for expanding the antigen-reactive B-cell clone, followed by selection and differentiation into centrocytes . During this germinal centre reaction, B-cell immunoglobulin genes undergo somatic hypermutation to produce higher-affinity immunoglobulin molecules. B cells in which hypermutation does not achieve this undergo apoptosis. The number of B cells that act as progenitors for a fully mature germinal centre is remarkably small; abundant centroblasts and centrocytes arise by extensive proliferation of only a few antigen-stimulated progenitor cells. The function of germinal centres is to generate immunoglobulin-secreting plasma cells and memory B cells in response to antigenic challenge.

A fully formed germinal centre is seen histologically as a round, pale structure in the cortex ( Fig. 22.1 ), surrounded by a rim of small lymphocytes termed the mantle zone . Distinct zonation may be seen within the germinal centre. A pale zone, facing towards the subcapsular sinus, is rich in centrocytes and T cells (specifically, T-follicular helper, or T FH , cells) and contains the greatest density of FDC. Facing towards the medulla is a darker zone rich in rapidly dividing centroblasts admixed with tingible body macrophages. The latter phagocytose debris from apoptosis of B cells following unsuccessful immunoglobulin gene hypermutation.

Fig. 22.1, Lymph node germinal centre.

B cells enter and leave the germinal centre through its mantle zone. In some lymph node reactions, and in reactive lymphoid tissue at extranodal sites, a population of post­germinal centre B cells may also accumulate outside the mantle zone; these are marginal zone B cells.

Paracortex

This is the main lymph node region for generating T-cell reactions and it therefore contains large numbers of T lymphocytes. There is a predominance of the helper/inducer T-cell subset expressing cluster of differentiation (CD) 4 antigen. As in the germinal centre, specialised antigen-presenting cells are present; these are interdigitating reticulum cells (IDRC) and they differ morphologically and functionally from FDC. They are derived from macrophages and possess abundant cytoplasm, with complex processes which interdigitate with neighbouring T cells. Large amounts of class II human leukocyte antigen (HLA) molecules are expressed on IDRC surfaces and this is important for interactions with immune cells, especially antigen presentation to CD4+ T cells. The paracortex also contains specialised blood vessels, termed high endothelial venules (HEV), which provide a specific route for T cells to leave the node.

Medulla

Lymph drains to the hilum through sinuses that converge in the medulla. These sinuses are lined by macrophages which phagocytose particles from lymphatic fluid. Between the sinuses lie medullary cords containing numerous antibody-secreting plasma cells. Many of the latter mature here from postgerminal centre B cells after their transit through mantle zones; medullary cords are a major site of antibody secretion.

Extranodal lymphoid tissue

Lymphoid tissue is present normally at several extranodal sites, particularly in Waldeyer's ring (tonsils and adenoids) and small intestinal Peyer's patches. It may be induced at additional sites by chronic immune stimulation, such as persistent infection or autoimmune inflammation. Examples include the stomach in chronic gastritis, caused by Helicobacter pylori , the thyroid gland in Hashimoto disease (autoimmune thyroiditis) and salivary glands in Sjögren syndrome (autoimmune sialadenitis). Periorbital lymphoid tissue may be induced by Chlamydia trachomatis, the causative organism of trachoma, and cutaneous lymphoid tissue by Borrelia burgdorferi that causes Lyme disease. Whether normal or induced, lymphoid tissue at these sites contains similar components to those found in lymph nodes. Additional elements are an outer marginal zone surrounding the follicular mantle, and distinct sites of lymphoid cell infiltration into epithelial structures. T cells are present in extranodal lymphoid tissue but organisation into a paracortex is generally absent.

Such lymphoid tissue collections are usually referred to as mucosa-associated lymphoid tissue (MALT) although not all sites of occurrence of induced MALT are mucosae. Normal MALT provides immunity against infective organisms and other antigens encountered at mucosa-lined body surfaces. Circulation of lymphocytes between MALT sites, via homing mechanisms distinct from those for circulation between lymph nodes, ensures specific mucosal immune memory and function; the predominant immunoglobulin type produced is IgA.

Lymph Node Enlargement (‘Lymphadenopathy’)

  • May be localised or generalised

  • If persistent, often requires biopsy for diagnosis

  • May be due to infection, autoimmunity or neoplasm

  • Neoplastic enlargement may be primary (e.g. lymphoma) or secondary (e.g. metastatic carcinoma)

Nonneoplastic Lymphadenopathy

Lymph nodes respond to a wide variety of inflammatory stimuli by cellular proliferation and aggregation, producing enlargement. The cell types involved differ, depending upon the nature of the antigenic stimulus, which may elicit:

  • a predominantly B-cell response with germinal centre hyperplasia, which may be associated with mantle and/or marginal zone expansion

  • a predominantly T-cell response with paracortical expansion

  • a predominantly macrophage response leading to granuloma formation or sinus histiocyte accumulation

  • most commonly, a mixed response in which combinations of lymph node cells are stimulated.

Nonspecific hyperplasia

Patterns of cellular proliferation and accumulation within a lymph node may give clues to the cause of lymphadenopathy. However, in many instances, such clues are absent and the features are termed nonspecific hyperplasia . Nonspecifically enlarged lymph nodes may reach a considerable size and be difficult to distinguish clinically and macroscopically from nodes involved by neoplastic disorders. Microscopically, numerous enlarged germinal centres are usually seen, present throughout the node and not restricted to the outer cortex as in the normal state. They are active, with a predominance of centroblasts and a high mitotic count; they often also contain numerous tingible body macrophages. In extranodal lymphoid tissue (e.g. tonsil or intestinal mucosa) and spleen, marginal zones may also be expanded. The paracortex usually shows reactivity characterised by scattered large, activated lymphoid cells, increased small T cells, scattered large, pale IDRC and prominent HEV. Lymph node sinuses are often dilated and have prominent lining macrophages, a reaction termed sinus histiocytosis .

Nonspecific hyperplasia may occur in lymph nodes adjacent to sites of infection. The pathogenic organisms may cause additional acute inflammatory changes, termed lymphadenitis , which may progress to abscess formation within affected nodes.

Specific reactive disorders

Some types of nonneoplastic lymphadenopathy have histological features allowing precise diagnosis. These may be grouped as:

  • granulomatous lymphadenitis

  • necrotising lymphadenitis

  • sinus histiocytosis

  • paracortical hyperplasia.

Granulomatous lymphadenitis

Granulomatous lymphadenitis can occur in a variety of clinical settings, such as mycobacterial infection, sarcoidosis and Crohn disease, which are described elsewhere ( Ch. 14 ) and will not be discussed further here.

Toxoplasmosis — infection with Toxoplasma gondii , a protozoal organism — in an immunocompetent individual produces a short, flu-like illness and localised lymphadenopathy, usually occipital or cervical, which persists for several weeks. Affected lymph nodes are enlarged with germinal centre hyperplasia and formation of adjacent ill-defined granulomas. In addition, there is florid marginal zone B-cell hyperplasia characterised by accumulation of medium-sized, monomorphic B cells adjacent to follicles and lymph node sinuses. This triad of follicular hyperplasia, follicle-associated granulomas and marginal zone B-cell hyperplasia ( Fig. 22.2 ) strongly suggests toxoplasmic lymphadenitis; the diagnosis is confirmed serologically.

Fig. 22.2, Toxoplasmic lymphadenitis.

Lymph nodes associated with lymphatics draining tumours occasionally show a granulomatous reaction in the absence of metastatic involvement, possibly a reaction to tumour antigens. Lymph nodes may also develop granulomas in response to foreign particles, for example, silicone compounds used in plastic surgery and joint replacement. Ink pigments are found commonly within paracortical macrophages in individuals who have heavy skin tattooing but these cells rarely aggregate to form granulomas.

Necrotising lymphadenitis

A variety of infections may cause necrosis within lymph nodes. Examples are lymphogranuloma venereum and cat-scratch disease . Lymphogranuloma venereum is a sexually transmitted chlamydial disease and most commonly affects inguinal lymph nodes. Cat-scratch disease follows a bite or scratch from an infected cat; days to weeks later, tender cervical or axillary lymphadenopathy develops; inguinal nodes are less commonly affected. Two organisms have been shown to be responsible for cat-scratch disease; Bartonella henselae causes up to 75% of cases while Afipia felis is less common. In immunosuppressed patients, particularly those with HIV/AIDS, infection with B. henselae may cause an unusual vascular proliferation termed bacillary angiomatosis . Lymphogranuloma venereum and cat-scratch disease show histological similarities, with stellate abscesses surrounded by palisaded macrophages ( Fig. 22.3 ).

Fig. 22.3, Cat-scratch disease.

A rare form of necrotising lymphadenitis is Kikuchi disease , in which tender cervical or occipital lymphadenopathy develops, most commonly in young adult Asian women. The cause is unknown and its pathology is more accurately attributed to extensive, confluent apoptosis within the lymph node rather than true necrosis, since absence of neutrophils from the necrotic tissue is striking. A florid macrophage and T-cell reaction occurs that may be mistaken for lymphoma. Systemic lupus erythematosus occasionally causes autoimmune lymphadenitis with very similar histology.

Sinus histiocytosis

This is a very common reaction in lymph nodes, particularly those associated with lymphatics draining neoplasms; its features have been described above ( p. 528 ). Sinus histiocytosis with massive lymphadenopathy (SHML or Rosai–Dorfman syndrome) is a rare condition of unknown cause that presents typically with bulky cervical lymphadenopathy in the first and second decades of life and may persist for several years. It may, however, affect individuals of any age and involve other tissues. Lymph node sinuses are distended by large, distinctive macrophages admixed with lymphocytes and plasma cells. Many lymphocytes and plasma cells appear to lie within macrophage cytoplasm because they pass through it in membrane-lined channels, a process termed emperipolesis . Molecular genetic analysis of SHML has shown it to be a polyclonal disorder; it usually follows a benign course and may regress spontaneously. However, in some patients with extensive disease the course is aggressive and fatalities have occurred.

Paracortical hyperplasia

Paracortical hyperplasia is prominent in many cases of lymphadenopathy. Two entities deserve special mention: dermatopathic lymphadenopathy and infectious mononucleosis (glandular fever).

Patients with chronic inflammatory skin conditions (e.g. severe eczema or psoriasis) and others with cutaneous T-cell lymphomas (CTCL) commonly develop enlarged inguinal and axillary lymph nodes; a condition known as dermatopathic lymphadenopathy . The enlarged lymph nodes may have yellow or buff-coloured cut surfaces and, microscopically, the paracortex is expanded by nodular collections of pale histiocytes admixed with small T lymphocytes. The histiocytes are predominantly IDRC, sometimes accompanied by conventional macrophages with visible intracytoplasmic lipid or skin-derived melanin.

Infectious mononucleosis is due to acute infection by Epstein–Barr virus (EBV). After an initial sore throat and flu-like illness, this causes widespread lymphadenopathy and is characterised, at least in later stages if lymph node enlargement persists, by paracortical expansion including numerous, large, activated B and T cells. This histological picture may be mistaken for lymphoma.

Human immunodeficiency virus infection

HIV binds to CD4, expressed by helper/inducer T cells and macrophages, and to the chemokine receptor CXCR4. Destruction of cells bearing CD4 causes severe immune impairment, ultimately leading to a profound immunodeficiency state called AIDS ( Ch. 8 ). Lymphadenopathy is extremely common in HIV infection. It may be widespread as well as persistent in the absence of any other secondary cause (e.g. mycobacterial infection). It may be accompanied by systemic symptoms in AIDS.

Morphology

Lymph nodes from patients infected with HIV show a spectrum of appearances that, although not absolutely specific, are virtually diagnostic in an appropriate clinical setting. Initially, follicles are extremely hyperplastic and often very irregular in shape ( Fig. 22.4 ) with sparse, poorly formed mantles. Ultrastructurally, proliferation of FDC is observed; retroviral particles lie between the complex, branching FDC processes. In some follicles, the FDC meshwork becomes broken up, accompanied by haemorrhage into the germinal centre and infiltration by mantle-type B cells and CD8+ T lymphocytes (‘ follicular lysis’ ). Any paracortical reaction is slight, with only scattered immunoblasts and activated lymphocytes, but there is reversal of the normal CD4:CD8 ratio among T cells, often with CD8+ cells predominating, and the proportion of antigen-naïve T cells is increased. Sinuses may be filled with marginal zone B cells.

Fig. 22.4, Lymphoid hyperplasia in HIV infection.

In later stages of HIV/AIDS, involutional changes are apparent with loss of germinal centre B cells and depletion of paracortical T cells. Sinus histiocytosis may be prominent. These changes are now seen much less frequently, with HIV diagnosis being made earlier and highly active antiretroviral therapy being available for many patients.

Complications

Lymphadenopathy in HIV/AIDS may not be due solely to immune dysregulation; a variety of neoplastic and infective conditions may also occur. Lymph node involvement by Kaposi sarcoma or high-grade B-cell non-Hodgkin lymphoma (NHL; often Burkitt lymphoma) is common. A wide variety of infections may cause lymph node enlargement, among which atypical mycobacterial infection is frequent ( Fig. 22.5 ).

Fig. 22.5, Mycobacterial infection in a lymph node in AIDS.

Neoplastic Lymphadenopathy

Neoplastic lymph node enlargement may occur in:

  • malignancies of lymphoid cells (Hodgkin and NHL) and associated stromal cells (histiocytic, FDC and IDRC tumours)

  • metastatic spread of solid tumours and involvement by leukaemia.

There are many different types of lymphoma. Diagnosis, treatment and understanding of their biology are assisted by a detailed, evolving classification system that has been developed by the World Health Organization (WHO) after many previous attempts by others. Within the WHO system, lymphomas are classified according to cell lineage ( Table 22.1 ). Within each lineage, disease entities are defined by a combination of clinical features, morphology, immunophenotype (spectrum of expression of antigenic molecules) and genotype, all of which are believed to reflect the cell of origin of the lymphoma, its normal functions and disturbance of those functions by genetic mutations. The aim of the WHO classification is to describe lymphoma entities that can be diagnosed consistently and have both biological and clinical relevance.

Table 22.1
World Health Organization classification of lymphoid neoplasms (summary of main entities as defined in 2017 revision)
Precursor neoplasms:
  • B-lymphoblastic leukaemia/lymphoma

  • T-lymphoblastic leukaemia/lymphoma

Mature (peripheral) B-cell neoplasms:
  • Chronic lymphocytic leukaemia/small lymphocytic lymphoma

  • B-cell prolymphocytic leukaemia

  • Lymphoplasmacytic lymphoma

  • Plasmacytoma

  • Plasma cell myeloma

  • Mantle cell lymphoma

  • Follicular lymphoma

  • Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue

  • Nodal marginal zone lymphoma

  • Splenic marginal zone lymphoma

  • Hairy cell leukaemia

  • Diffuse large B-cell lymphoma (DLBCL; several subtypes)

  • Burkitt lymphoma

  • High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

  • B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma

Mature (peripheral) T/NK-cell neoplasms:
  • Mainly leukaemic:

    • T-cell prolymphocytic leukaemia

    • T-cell large granular lymphocytic leukaemia

    • Adult T-cell leukaemia/lymphoma

  • Mainly node-based:

    • Peripheral T-cell lymphoma, not otherwise specified

    • Angioimmunoblastic T-cell lymphoma

    • Anaplastic large cell lymphoma (ALK-positive and ALK-negative variants)

  • Mainly extranodal:

    • Extranodal NK/T-cell lymphoma, nasal type

    • Enteropathy-associated T-cell lymphoma

    • Hepatosplenic T-cell lymphoma

    • Mycosis fungoides and Sézary syndrome

    • Primary cutaneous CD30-positive T-cell lymphoproliferative disorders

Hodgkin lymphoma
  • Nodular lymphocyte-predominant Hodgkin lymphoma

  • Classic Hodgkin lymphoma:

    • Nodular sclerosis classic Hodgkin lymphoma

    • Lymphocyte-rich classic Hodgkin lymphoma

    • Mixed cellularity classic Hodgkin lymphoma

    • Lymphocyte-depleted classic Hodgkin lymphoma

Hodgkin lymphoma

The first detailed account of pathology relating to the disease that bears his name was made by Thomas Hodgkin in 1832. Hodgkin's observations were based purely on macroscopic appearances of enlarged lymph nodes at autopsy and it was some years before microscopic studies were undertaken. Over ensuing decades, a gradual awareness of the histopathology of Hodgkin disease (now called ‘ Hodgkin lymphoma ’) emerged, including descriptions of the characteristic neoplastic cells by Sternberg (1898) and Reed (1902). We now know that some of Hodgkin's original cases were examples of tuberculosis but this does not detract from the seminal nature of his observations.

Many attempts have been made to subclassify Hodgkin lymphoma into clinically meaningful groups, of which the most successful was based on histological variation and proposed by Lukes and Butler in 1966. This has been incorporated in modified form within the WHO classification (see Table 22.1 ), which recognises several classic Hodgkin lymphoma (cHL) subtypes and the separate condition of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).

The distinctive malignant cells of cHL form only a small percentage of the cellular population within affected lymph nodes. Most of the tissue is composed of reactive lymphocytes, macrophages, plasma cells and eosinophils attracted into involved sites by a variety of cytokines secreted by Hodgkin and Reed–Sternberg (HRS) cells. This relative paucity of HRS cells has hampered efforts to define their origin but elegant microdissection studies have now isolated single HRS cells for molecular genetic analysis. These have shown that, in almost all cases, HRS cells have a clonal IGH rearrangement, indicating that they are derived from B lymphocytes. In addition, they show evidence of somatic hypermutation of the rearranged immunoglobulin genes, indicating origin from a postgerminal centre B cell. In cHL, the neoplastic B cells have defective expression of critical transcription factors required for immunoglobulin production, either OCT2 or BOB1 or both. In approximately 25% of patients, HRS cells have additional crippling mutations of their immunoglobulin genes. The lack of transcription factors and these crippling mutations prevent production of functional immunoglobulin molecules. Latent EBV infection is implicated in causing these abnormalities in up to 50% of patients. They are also associated with increased intracellular nuclear factor (NF)-kappa B activity in HRS cells, which is believed to contribute to their proliferation and distinctive patterns of cytokine production.

NLPHL differs from cHL in having intact immunoglobulin transcription factors, no crippling mutations and no association with EBV. Neoplastic cells in NLPHL show evidence of ongoing immunoglobulin gene hypermutation, in keeping with origin from a B cell still responsive to the germinal centre microenvironment. These differences emphasise the biological distinction between NLPHL and cHL.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here